$CTMX has generated 12 mentions over the past 12 months from 2 distinct FinTwit voices, with the first mention appearing on July 25, 2025. Jacob Plieth (@jacobplieth) has been the dominant voice discussing the company, accounting for 11 of the 12 mentions, while Adam Feuerstein (@adamfeuerstein) contributed 1 mention. The biotech category represents the primary focus for discussions of $CTMX among these voices.

Most recent activity around $CTMX occurred in mid-March 2026, with Plieth noting developments regarding the company's varseta-M candidate and efficacy data. Plieth observed that while efficacy metrics showed changes, the varseta-M program maintained positive momentum, with shares trading up 64% at the time of his latest commentary on March 16, 2026.